3/24/2010

Meridian Bioscience has filed an application with the FDA seeking 510(k) clearance for its illumigene test, which detects Clostridium difficile in a patient's stool sample using loop amplification. The molecular amplification test can generate results in less than 60 minutes.

Related Summaries